Deuruxolitinib (CTP-543) is the hexa-deuterated form of Ruxolitinib, which is a marketed JAK1/JAK2 inhibitor. Deuruxolitinib is being studied in clhical trials for treating Alopecia Areata (a form of hair loss).

纯度：≥98%

CAS：1513883-39-0